Clinical Trials
>
Urinary Tract / Bladder Cancer

PCYC-1128-CA

A Phase1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors (Bladder, Colon, Gastric, Renal).

S1605

Phase II Trial of Atezolizumab in BCG-Unresponsive Non- Muscle Invasive Bladder Cancer.